Answers are grounded in this paper and cite their sources.
Retroperitoneal diffuse large B-cell lymphoma (DLBCL) is generally rare and often presents with late symptoms. A 60-year-old female presented with abdominal pain for 3 days with associated symptoms of altered bowel habits and constitutional symptoms. Physical examination was unremarkable. The blood investigations were generally within normal limits except for a 10-fold rise in serum CA-125. Transabdominal ultrasonography revealed an ill-defined lesion, with a cystic component within, at the inferior pole of the spleen. Computed tomography scan showed a large lobulated soft tissue tumour in the left retroperitoneal space with local infiltration to adjacent organs with multiple subcentimeter para-aortic and aortocaval lymph nodes. Laparotomy revealed a locally advanced retroperitoneal tumour measuring 10 x 10cm in size. The left retroperitoneal tumour was resected en-bloc with the left kidney, the spleen, the distal part of the pancreas and a part of the left diaphragm. Histopathological examination of the retroperitoneal tumour revealed a DLBCL (germinal centre type) as CD10, CD20, and BCL-6 were positive among all the markers, confirming the final diagnosis. She was started on CHOP regimen chemotherapy and is currently well. A complete en-bloc resection of the retroperitoneal lymphoma is recommended in fit patients with resectable retroperitoneal tumours. The decision between core needle biopsy and surgical resection should be made on a case-by-case basis following a multidisciplinary team approach discussion to achieve the best outcome for these patients.
No takes yet. Share an insight, caveat, or question.
Hoe et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: